This article has been updated from a previous version to include comments from Bio-Rad's earnings call.

NEW YORK (GenomeWeb) – Bio-Rad said after the close of the market Thursday that its third quarter revenues increased 5 percent year over year.

For the three months ended Sept. 30, the Hercules, California-based life science research and clinical diagnostics firm tallied sales of $535.0 million compared to $508.7 million in the year-ago period, beating analysts' average estimate of $508 million. On a currency-neutral basis, net sales grew 3 percent in the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease.